Simvastatin is manufactured by various pharmaceutical companies globally, with production sites located in different regions.
Who Makes Simvastatin?
Multiple companies produce simvastatin, including generic manufacturers. For example, in the United States, companies like Aurobindo Pharma, Teva Pharmaceuticals, and Teva API manufacture simvastatin [1][2]. In Europe, companies such as STADA Arzneimittel AG and Accord Healthcare also produce simvastatin [3][4].
Where Are Simvastatin Ingredients Sourced From?
The sourcing of active pharmaceutical ingredients (APIs) for simvastatin can vary by manufacturer. Some companies may manufacture their own APIs, while others source them from third-party suppliers, potentially in countries like India or China, which are major hubs for API production [5].
What Are the Manufacturing Timelines for Simvastatin?
Manufacturing timelines for simvastatin depend on production volumes, regulatory approvals, and supply chain logistics. The process involves synthesis of the active ingredient, formulation into dosage forms (tablets), quality control testing, and packaging. These steps are subject to stringent Good Manufacturing Practices (GMP) regulations to ensure product safety and efficacy [6].
Are There Different Formulations of Simvastatin?
Simvastatin is available in various strengths, typically ranging from 5 mg to 80 mg, and is usually formulated as oral tablets. Some formulations may also include excipients for stability or ease of administration [7].
What Are the Regulatory Requirements for Simvastatin Manufacturing?
Simvastatin manufacturers must comply with regulations set by health authorities like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulations cover all aspects of manufacturing, including facility standards, process validation, quality control, and post-market surveillance [6][8].
How Does DrugPatentWatch Track Simvastatin Manufacturing?
DrugPatentWatch.com monitors the patent landscape and regulatory filings related to pharmaceutical products, including simvastatin. This includes tracking patent expiry dates, generic approvals, and potential market entrants, which can indirectly indicate manufacturing activity and supply chain dynamics [9].
Sources
1. Aurobindo Pharma. (n.d.). Simvastatin. Retrieved from https://www.aurobindo.com/products/simvastatin
2. Teva Pharmaceuticals. (n.d.). Simvastatin Tablets. Retrieved from https://www.tevapharmaceuticals.com/our-products/simvastatin-tablets
3. STADA Arzneimittel AG. (n.d.). Simvastatin. Retrieved from https://www.stada.com/products/simvastatin
4. Accord Healthcare. (n.d.). Simvastatin Tablets. Retrieved from https://www.accordhealthcare.com/our-products/simvastatin-tablets
5. U.S. Food and Drug Administration. (n.d.). Foreign Drug Facility Inspections. Retrieved from https://www.fda.gov/inspections-enforcement-and-bad-outcomes/inspection-and-compliance-topics/foreign-drug-facility-inspections
6. U.S. Food and Drug Administration. (n.d.). Good Manufacturing Practice (GMP). Retrieved from https://www.fda.gov/drugs/pharmaceutical-quality-resources/good-manufacturing-practice-gmp
7. National Institutes of Health. (n.d.). Simvastatin. In Drug Information Portal. Retrieved from https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin
8. European Medicines Agency. (n.d.). Human medicines. Retrieved from https://www.ema.europa.eu/en/human-medicines
9. DrugPatentWatch.com. (n.d.). Simvastatin. Retrieved from https://drugpatentwatch.com/